Integrated genomic characterization of endometrial carcinoma
Authors:
- The Cancer Genome Atlas Research NetworkTNThe Cancer Genome Atlas Research Network
- Douglas A. LevineDLDouglas A. Levine
Top Cited Papers
Open Access
- 1 May 2013
- journal article
- research article
- Published by Springer Nature in Nature
- Vol. 497 (7447) , 67-73
Abstract
We performed an integrated genomic, transcriptomic and proteomic characterization of 373 endometrial carcinomas using array- and sequencing-based technologies. Uterine serous tumours and ∼25% of high-grade endometrioid tumours had extensive copy number alterations, few DNA methylation changes, low oestrogen receptor/progesterone receptor levels, and frequent TP53 mutations. Most endometrioid tumours had few copy number alterations or TP53 mutations, but frequent mutations in PTEN, CTNNB1, PIK3CA, ARID1A and KRAS and novel mutations in the SWI/SNF chromatin remodelling complex gene ARID5B. A subset of endometrioid tumours that we identified had a markedly increased transversion mutation frequency and newly identified hotspot mutations in POLE. Our results classified endometrial cancers into four categories: POLE ultramutated, microsatellite instability hypermutated, copy-number low, and copy-number high. Uterine serous carcinomas share genomic features with ovarian serous and basal-like breast carcinomas. We demonstrated that the genomic features of endometrial carcinomas permit a reclassification that may affect post-surgical adjuvant treatment for women with aggressive tumours.Keywords
This publication has 41 references indexed in Scilit:
- Exome sequencing of serous endometrial tumors identifies recurrent somatic mutations in chromatin-remodeling and ubiquitin ligase complex genesNature Genetics, 2012
- Comprehensive molecular portraits of human breast tumoursNature, 2012
- Comprehensive molecular characterization of human colon and rectal cancerNature, 2012
- Integrated genomic analyses of ovarian carcinomaNature, 2011
- Identification of a CpG Island Methylator Phenotype that Defines a Distinct Subgroup of GliomaCancer Cell, 2010
- Phase II trial of trastuzumab in women with advanced or recurrent, HER2-positive endometrial carcinoma: A Gynecologic Oncology Group studyGynecologic Oncology, 2010
- A comprehensive catalogue of somatic mutations from a human cancer genomeNature, 2009
- Integrative clustering of multiple genomic data types using a joint latent variable model with application to breast and lung cancer subtype analysisBioinformatics, 2009
- Integrated genomic profiling of endometrial carcinoma associates aggressive tumors with indicators of PI3 kinase activationProceedings of the National Academy of Sciences, 2009
- Frequent activating FGFR2 mutations in endometrial carcinomas parallel germline mutations associated with craniosynostosis and skeletal dysplasia syndromesOncogene, 2007